Patent details

Basic Information

Publication number:

EP2989202

PCT Application Number:

US2014035325

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP147276703

PCT Publication Number:

WO2014176439

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

THE USE OF LAMBDA-GAM PROTEIN IN RIBOSOMAL DISPLAY TECHNOLOGY

French Title of Invention:

L'UTILISATION DE LA LAMBDA-GAM PROTÉINE DANS LA TECHNOLOGIE DE RIBOSOME DISPLAY

German Title of Invention:

DIE VERWENDUNG DES LAMBDA-GAM PROTEINS IN DER RIBOSOMEN-DISPLAY-TECHNOLOGIE

SPC Number:

Dates

Filing date:

24/04/2014

Grant date:

10/04/2019

EP Publication Date:

02/03/2016

PCT Publication Date:

30/10/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/04/2019

EP B1 Publication Date:

10/04/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

24/04/2019

Expiration date:

24/04/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/04/2019

 

 

Name:

Sutro Biopharma, Inc.

Address:

310 Utah Avenue, Suite 150, South San Francisco, California 94080, United States (US)

Inventor

1

Name:

THANOS, Christopher D.

Address:

United States (US)

2

Name:

STAFFORD, Ryan

Address:

United States (US)

Priority

Priority Number:

201361815951 P

Priority Date:

25/04/2013

Priority Country:

United States (US)

Classification

IPC classification:

C12N 15/10;

Publication

European Patent Bulletin

Issue number:

201915

Publication date:

10/04/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages